期刊文献+

紫草膏治疗儿童特应性皮炎的疗效观察 被引量:5

下载PDF
导出
摘要 目的初步评价紫草膏治疗轻度儿童特应性皮炎(AD)的疗效和安全性,并分析其作用机制.方法儿童特应性皮炎(AD)患者200例,编号后随机分为观察组和对照组,每组各100例.观察组给予盐酸西替利嗪片口服,局部外用院内制剂紫草膏;对照组在观察组系统治疗的基础上外用丁酸氢化可的松乳膏.观察比较两组患者治疗前后的SCORAD评分、皮损区和正常皮肤的角质层含水量、经表皮水分丢失量(TEWL)、pH值等.结果治疗后两组SCORAD评分均下降,两组角质层含水量均上升,经表皮水分丢失量(TEWL)减少、pH值降低.结论紫草膏外用治疗AD疗效确切,且副作用少,安全性高. Objective To preliminarily evaluate the efficacy and safety of Zicao Ointment in the treatment of mild atopic dermatitis(AD)in children,and analyze its mechanism of action.Methods 200 children with atopic dermatitis(AD)were randomly divided into observation group and control group after numbering,with 100 cases in each group.The observation group was given cetirizine hydrochloride tablets orally,and topical in-hospital preparation zicao ointment was used locally;the control group was given topical hydrocortisone butyrate cream based on systemic treatment in the observation group.The SCORAD score,skin lesion area and normal skin stratum corneum water content,transepidermal water loss(TEWL),pH value,etc.were observed and compared before and after treatment between the two groups.Results After treatment,the SCORAD scores of the two groups decreased,the water content of the stratum corneum in both groups increased,the amount of transepidermal water loss(TEWL)decreased,and the pH value decreased.Conclusion The external use of Zicao ointment has a definite curative effect in the treatment of AD,with few side effects and high safety.
出处 《浙江临床医学》 2021年第4期536-538,共3页 Zhejiang Clinical Medical Journal
基金 浙江省中医药科技计划(2017ZB037)。
关键词 特应性皮炎 紫草膏 皮肤屏障 Atopic dermatitis Zicao ointment Skin barrier
  • 相关文献

参考文献5

二级参考文献43

  • 1扈爱清,丰玉霞,刘洪秀,梁晶,杜慧,王凤侠.三黄紫草油治疗婴儿尿布皮炎、烫伤的临床观察[J].齐鲁护理杂志,2005,11(4):296-297. 被引量:8
  • 2国家统计局.人口与就业统计司中国人口统计年鉴(1997年)[M].北京:中国统计出版社,1997..
  • 3Lotti T, Buggiani G, Prignano F.Prurigo nodularis and lichen simplex chronicus. Dermatol Ther, 2008,21(1):42-46.
  • 4Thorstensen KA, Birenbaum DL.Recognition and management of vulvar dermatologic conditions: lichensclerosus, lichen planus, and lichen simplex chronicus.J Midwifery Womens Health, 2012,57(3):260-75.
  • 5Mlitz V, Latreille J, Gardinier S, et al. Impact of filaggrin muta- tions on Roman spectra and biophysical properties of the stratum corneum in mild to moderate atopic dermatitis [ J ]. J Eur Acad Dermatol Venereol, 2012, 26(8) : 983 - 990.
  • 6Kezic S, O'Regan GM, Yan N, et al. Levels of filaggrin degrada- tion products are influenced by both filaggrin genotype and atopic dermatitis severity[J]. Allergy, 2011, 66(7) :934 - 940.
  • 7Morar N, Edster P, Street T, et al. Fine mapping of susceptibili- ty genes for atopic dermatitis in the epidermal differentiation com- plex on chromosome lq21 [J ]. Br J Dermatol, 2007, 157 : 3.
  • 8Rosanne A HMvan den Oord. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review andmeta- analysis[J]. British Medical Journal, 2009, 339: 24 - 33.
  • 9Paternoster L, Standl M, Chen CM, et al. Meta - analysis of genome - vide association studies identifies three new risk loci for atopic; dermatitis[J]. Nat Genet, 2011, 44:87 - 192.
  • 10Mrabet - Dahbi S, Dalpke AH, Renz H. The Toll - like receptor 2 R753Q mutation modifies cytokine production and Toll - like re- ceptor expression in atopic dermatitis[J ]. J Allergy Clin Immunol, 2008, 121:1 013- 1 019.

共引文献155

同被引文献40

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部